PI
VNDA icon

PineBridge Investments’s Vanda Pharmaceuticals VNDA Stock Holding History

PineBridge Investments’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-39,864
Closed -$654K – 1028
2019
Q4 		$654K Sell
39,864
-27,425
-41% -$415K 0.01% 787
2019
Q3 		$894K Buy
67,289
+12,449
+23% +$173K 0.01% 793
2019
Q2 		$772K Buy
54,840
+40,307
+277% +$641K 0.01% 741
2019
Q1 		$267K Sell
14,533
-2,104
-13% -$47.9K 0.01% 811
2018
Q4 		$435K Buy
+16,637
New +$391K 0.01% 719

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

PineBridge Investments's VNDA Position: Q1 2020 in Review

PineBridge Investments sold out of Vanda Pharmaceuticals (VNDA) in Q1 2020, closing a stake of 39,864 shares — an estimated $654K sold.

PineBridge Investments first reported a position in VNDA in Q4 2018 and held it in 5 quarters. The position peaked at $894K in Q3 2019. 159 funds tracked by Wall St. Rank hold VNDA as of Q1 2020.

  • PineBridge Investments reported no remaining Vanda Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • PineBridge Investments sold 39,864 Vanda Pharmaceuticals shares in Q1 2020, an estimated $654K.
  • PineBridge Investments first reported a position in Vanda Pharmaceuticals in Q4 2018 and held it in 5 quarters.
  • PineBridge Investments's Vanda Pharmaceuticals position peaked at $894K in Q3 2019.
  • 159 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2020.

Based on PineBridge Investments's 13F filing for Q1 2020, filed 14 May 2020.